Skip to main content
Clinical Trials/NCT01429480
NCT01429480UnknownNot Applicable

Comparison Between Two Ultrasound-guided Blocks (Transversus Abdominis Plane and Ilioinguinal/Iliohypogastric Nerve Blocks) for Pain Relief After Open Inguinal Herniorrhaphy

Hillel Yaffe Medical Center1 site in 1 country90 target enrollmentStarted: August 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
90
Locations
1
Primary Endpoint
postoperative pain

Study Overview

Brief Summary

TAP was recommended by PROSPECT for further investigation as an appropriate analgesic method after open herniorrhaphy. Ilioinguinal/iliohypogastric nerve block is one of the oldest methods of analgesia. The researchers wish to investigate whether the TAP block is as effective as the ilioinguinal/iliohypogastric nerve block?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing elective primary unilateral open tension-free mesh inguinal hernia repair

Exclusion Criteria

  • Inability to consent to the study
  • BMI more than 40
  • Skin infection near injection site
  • Chronic hepatic or renal failure
  • Peripheral neuropathy
  • Proven opioid dependency
  • Coagulopathy
  • Thrombocytopenia
  • Lack of orientation
  • Impossibility to understand VAS
  • Patients suffering from chronic pain

Arms & Interventions

TAP Block

Active Comparator

Intervention: Preoperative Ultrasound Guided Posterior TAP Block (Procedure)

II/IH Block

Active Comparator

Intervention: Preoperative Ultrasound Guided Ilioinguinal/Iliohypogastric Block (Procedure)

Control Group

Active Comparator

Intervention: Patient controlled analgesia (Drug)

Outcomes

Primary Outcomes

postoperative pain

Time Frame: 2 days postoperatively

Intensity of pain in rest and during movement at the operation day and 2 days postoperaive.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials